Evotec SE (EVO) Cash & Equivalents (2009 - 2026)
Evotec SE (EVO) posted Cash & Equivalents of $454146.3 for Q1 2026, up 93120.93% sequentially from $487.17 in Q4 2025, and up 51.29% YoY from $300183.6 in Q1 2025.
Evotec SE (EVO) Cash & Equivalents (2009 - 2026) Analysis & Trends
Evotec SE has reported Cash & Equivalents for 10 years, with the latest figure at $454146.3 in Q1 2026.
- Quarterly Cash & Equivalents rose 51.29% year-over-year to $454146.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $454146.3 (up 51.29% YoY) and the FY2025 annual result came in at $487.17, down 100.0% from the prior year.
- Cash & Equivalents climbed to $454146.3 in Q1 2026 per EVO's latest filing, from $487.17 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $741.3 billion in Q1 2022 and troughed at $487.17 in Q4 2025.
- A 5-year average of $76.7 billion and a median of $467751.6 in 2022 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents plunged 100.0% in 2025, then jumped 51.29% in 2026.
- Over 5 years, Cash & Equivalents stood at $423.6 million in 2022, then grew by 29.78% to $549.7 million in 2023, then slumped by 40.44% to $327.4 million in 2024, then tumbled by 100.0% to $487.17 in 2025, then soared by 93120.93% to $454146.3 in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $454146.3, $487.17, and $203460.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | 454,146.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 454,146.29 |
| Dec 31, 2025 | 487.17 |
| Sep 30, 2025 | 203,460.01 |
| Jun 30, 2025 | 303,167.10 |
| Mar 31, 2025 | 300,183.63 |
| Dec 31, 2024 | 327.40 Mn |
| Sep 30, 2024 | 254.02 Bn |
| Mar 31, 2024 | 465,300.69 |
| Dec 31, 2023 | 549.71 Mn |
| Dec 31, 2022 | 423.56 Mn |
| Sep 30, 2022 | 467,751.57 |
| Jun 30, 2022 | 743,729.98 |
| Mar 31, 2022 | 741.29 Bn |
| Dec 31, 2021 | 800.01 Mn |
| Sep 30, 2021 | 393.18 Bn |
| Dec 31, 2020 | 503.84 Mn |
| Dec 31, 2019 | 306.65 Mn |
| Sep 30, 2010 | 24.27 Bn |
| Jun 30, 2010 | 42,545.15 |
| Mar 31, 2010 | 34.40 Mn |